Antimicrobial resistance is a growing health crisis that could lead to millions of deaths by 2050, according to the World ...
One of the most significant challenges in cancer treatment is the development of drug resistance by cancer cells, which often ...
The intravenous antibiotic Emblaveo, a combination of aztreonam and avibactam approved in Europe last year, was developed in ...
A research team affiliated with UNIST has unveiled an innovative technology to eliminate drug-resistant cancer cells using ...
A new case report was published in Volume 16 of Oncotarget on February 5, 2025, titled “Acquired RUFY1-RET rearrangement as a ...
Scientists have discovered three powerful new drug regimens that offer more effective treatment for tuberculosis—bringing ...
A groundbreaking cannabinoid-based antimicrobial, Silvanex, fights drug-resistant infections with a synergy of silver, CBC ...
Chennai: An increase in drug resistance is causing concern among leprosy patients, the state branch of the Indian Association ...
The endTB trial is one of four recent randomized controlled trials testing new, shorter, and less toxic treatment regimens ...
A randomized clinical trial conducted in seven countries has identified three new options for shorter, all-oral treatment of ...
According to the officials, the new regimen, called BPaL/BPaLM, includes medications bedaquiline, pretomanid, linezolid, and ...
A new case report details a novel genetic mutation linked to drug resistance in a non-small cell lung cancer patient ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results